Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

618

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

December 31, 2012

Study Completion Date

February 29, 2016

Conditions
Multiple Sclerosis
Interventions
DRUG

Teriflunomide

Film-coated tablet Oral administration

DRUG

Placebo

Film-coated tablet Oral administration

Trial Locations (131)

1000

Investigational Site Number 5307, Sofia

1010

Investigational Site Number 4001, Vienna

1076

Investigational Site Number 7101, Budapest

1145

Investigational Site Number 7103, Budapest

1407

Investigational Site Number 5304, Sofia

1431

Investigational Site Number 5309, Sofia

1527

Investigational Site Number 5303, Sofia

1606

Investigational Site Number 5306, Sofia

2500

Investigational Site Number 7108, Esztergom

3050

Investigational Site Number 1401, Parkville

3081

Investigational Site Number 1404, Heidelberg

3220

Investigational Site Number 1405, Geelong

4020

Investigational Site Number 4005, Linz

5800

Investigational Site Number 5312, Pleven

6020

Investigational Site Number 4004, Innsbruck

6700

Investigational Site Number 6004, Esbjerg

7001

Investigational Site Number 1407, Hobart

8000

Investigational Site Number 6002, Aarhus C

8200

Investigational Site Number 7105, Veszprém

10617

Investigational Site Number 6201, Tallinn

10713

Investigational Site Number 6810, Berlin

10785

Investigational Site Number 6805, Berlin

14029

Investigational Site Number 8507, Chernihiv

20100

Investigational Site Number 6401, Turku

21005

Investigational Site Number 8503, Vinnytsia

25030

Investigational Site Number 6611, Besançon

28204

Investigational Site Number 8941, Charlotte

30029

Investigational Site Number 6614, Nîmes

30625

Investigational Site Number 6809, Hanover

31203

Investigational Site Number 7501, Chihuahua City

32429

Investigational Site Number 6815, Minden

32761

Investigational Site Number 8920, Maitland

33701

Investigational Site Number 8953, St. Petersburg

34295

Investigational Site Number 6604, Montpellier

34390

Investigational Site Number 8309, Istanbul

34400

Investigational Site Number 8315, Istanbul

35058

Investigational Site Number 8965, Cullman

35100

Investigational Site Number 8305, Izmir

35340

Investigational Site Number 8301, Izmir

35380

Investigational Site Number 8303, Izmir

36011

Investigational Site Number 8510, Poltava

41380

Investigational Site Number 8302, İzmit

43005

Investigational Site Number 8512, Lutsk

44093

Investigational Site Number 6605, Nantes

45110

Investigational Site Number 7502, Guadalajara

45122

Investigational Site Number 6803, Essen

45409

Investigational Site Number 8924, Dayton

46256

Investigational Site Number 8940, Indianapolis

48149

Investigational Site Number 6802, Münster

49027

Investigational Site Number 8501, Dnipropetrovsk

49503

Investigational Site Number 8955, Grand Rapids

49684

Investigational Site Number 8949, Traverse City

50005

Investigational Site Number 5803, Hradec Králové

50406

Investigational Site Number 6203, Tartu

54036

Investigational Site Number 6612, Nancy

59037

Investigational Site Number 6609, Lille

61018

Investigational Site Number 8506, Kharkiv

61080

Investigational Site Number 8314, Trabzon

61178

Investigational Site Number 8504, Kharkiv

63003

Investigational Site Number 6601, Clermont-Ferrand

63104

Investigational Site Number 8914, Fort Wayne

Investigational Site Number 8937, St Louis

64711

Investigational Site Number 6807, Erbach im Odenwald

65191

Investigational Site Number 6806, Wiesbaden

65691

Investigational Site Number 5801, Brno

67063

Investigational Site Number 6804, Ludwigshafen

67091

Investigational Site Number 6607, Strasbourg

69000

Investigational Site Number 8502, Zaporizhzhya

70210

Investigational Site Number 6403, Kuopio

70852

Investigational Site Number 5805, Ostrava - Poruba

71103

Investigational Site Number 8922, Shreveport

77520

Investigational Site Number 5804, Olomouc

78681

Investigational Site Number 8905, Round Rock

79010

Investigational Site Number 8505, Lviv

80528

Investigational Site Number 8962, Fort Collins

83099

Investigational Site Number 8511, Donets'K

85060

Investigational Site Number 8946, Phoenix

87131

Investigational Site Number 8951, Albuquerque

95445

Investigational Site Number 6801, Bayreuth

98122

Investigational Site Number 8963, Seattle

194044

Investigational Site Number 7911, Saint Petersburg

214019

Investigational Site Number 7905, Smolensk

300736

Investigational Site Number 7808, Timișoara

344085

Investigational Site Number 7910, Rostov-on-Don

400012

Investigational Site Number 7805, Cluj-Napoca

Investigational Site Number 7807, Cluj-Napoca

420021

Investigational Site Number 7907, Kazan'

603000

Investigational Site Number 7909, Nizhny Novgorod

603076

Investigational Site Number 7906, Nizhny Novgorod

603126

Investigational Site Number 7904, Nizhny Novgorod

630007

Investigational Site Number 7912, Novosibirsk

2520997

Investigational Site Number 5605, Viña del Mar

85013-4496

Investigational Site Number 8954, Phoenix

10029-6574

Investigational Site Number 8925, New York

05401

Investigational Site Number 8930, Burlington

J4V 2J2

Investigational Site Number 5402, Greenfield Park

N6A 5A5

Investigational Site Number 5403, London

H1T 2M4

Investigational Site Number 5409, Montreal

K1H 8L6

Investigational Site Number 5401, Ottawa

G1J 1Z4

Investigational Site Number 5406, Québec

J1H 5N4

Investigational Site Number 5408, Sherbrooke

M4N 3M5

Investigational Site Number 5410, Toronto

M5B 1W8

Investigational Site Number 5404, Toronto

760-0746

Investigational Site Number 5602, Santiago

Unknown

Investigational Site Number 5601, Santiago

Investigational Site Number 5606, Santiago

Investigational Site Number 8304, Edirne

Investigational Site Number 8308, Istanbul

Investigational Site Number 8310, Istanbul

Investigational Site Number 8312, Istanbul

00100

Investigational Site Number 6405, Helsinki

06002

Investigational Site Number 6602, Nice

LT-92288

Investigational Site Number 7402, Klaipėda

LT-76231

Investigational Site Number 7403, Šiauliai

LT-08661

Investigational Site Number 7401, Vilnius

80-803

Investigational Site Number 7709, Gdansk

93-513

Investigational Site Number 7710, Lodz

02-097

Investigational Site Number 7701, Warsaw

02-957

Investigational Site Number 7703, Warsaw

04-141

Investigational Site Number 7707, Warsaw

020125

Investigational Site Number 7803, Bucharest

050098

Investigational Site Number 7806, Bucharest

03110

Investigational Site Number 8508, Kiev

L9 7LJ

Investigational Site Number 8709, Liverpool

E1 1BB

Investigational Site Number 8701, London

SW17 0QT

Investigational Site Number 8704, London

NE1 4LP

Investigational Site Number 8706, Newcastle upon Tyne

NG7 2UH

Investigational Site Number 8705, Nottingham

PL6 5BX

Investigational Site Number 8708, Plymouth

M6 8HD

Investigational Site Number 8707, Salford

S10 2JF

Investigational Site Number 8702, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00622700 - Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis | Biotech Hunter | Biotech Hunter